drugset
Drugs / Influenza Virus Vaccine, Trivalent, Inactivated
last change Jun 2003 re-read 2 minutes ago

Influenza Virus Vaccine, Trivalent, Inactivated

also known as TIV

Vaccine

Developed for
respiratory tract infectious disorder
Investigated by
MedImmune LLC · Wyeth is now a wholly owned subsidiary of Pfizer

Trials 1 · a red edge is where a trial was stopped

today NCT00192205 · Ph 3
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT00192205 Oct 2002 → Jun 2003 respiratory tract infectious disorder MedImmune LLC Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Influenza Virus Vaccine, Trivalent, Inactivated “Influenza Virus Vaccine, Trivalent, Inactivated (TIV)” NCT00192205 ↗
Known as TIV ClinicalTrials.gov intervention name — accepted as the source's own label NCT00192205 ↗
Modality Vaccine “Influenza Virus Vaccine, Trivalent, Inactivated (TIV)” NCT00192205 ↗